Danone S.A. (BN.PA) closed on EURONEXT at €74.12 on 19 Feb 2026 as markets shut, with earnings due on 20 Feb 2026. The BN.PA stock move of +2.55% on the day reflects investor positioning ahead of the report. Traders will watch EPS, margin trends, and management guidance for 2026. This earnings spotlight summarises valuation, key metrics, risks from recent product recalls, and what those factors mean for near-term price action.
BN.PA stock: trading snapshot and earnings timing
BN.PA stock closed €74.12 on EURONEXT with 1,577,449 shares traded, above the average volume of 1,366,344. Day range was €72.50–€74.16 and year range remains €63.52–€80.14. Danone reports results on 20 Feb 2026, so the market closed positioned for a near-term earnings reaction and guidance update.
Earnings preview: what to watch in the BN.PA earnings report
Investors should focus on EPS momentum and margins. Trailing EPS is €2.85 with a trailing PE of 26.01. Management may comment on Specialized Nutrition recovery and pricing in Waters and Essential Dairy & Plant-Based. Key metrics to watch are organic sales growth, adjusted operating margin, and free cash flow per share near €4.44.
Meyka AI grade and BN.PA stock forecast
Meyka AI rates BN.PA with a score out of 100: 74.18 (B+) — Suggestion: BUY. This grade factors in S&P 500 and sector comparison, financial growth, key metrics, analyst consensus, and forecast models. Meyka AI’s forecast model projects monthly €76.88, quarterly €79.65, and yearly €85.41. Compared with the current €74.12, the model implies near-term upside of 3.72% (monthly), 7.46% (quarterly), and 15.23% (yearly). Forecasts are model-based projections and not guarantees.
Valuation and fundamentals for BN.PA stock
Danone shows steady cash generation with operating cash flow per share €5.95 and free cash flow per share €4.44. Price-to-sales is 1.74, price-to-book is 3.00, and dividend per share is €2.15, a yield near 2.97%. Net debt to EBITDA stands around 2.86x and debt/equity is 0.92, which leaves leverage moderate for the sector but worth monitoring if margins compress.
Technicals and sector context for BN.PA stock
Technically BN.PA shows neutral momentum: RSI 53.37 and MACD histogram turning positive. ADX at 35.14 signals a strong trend context. Short-term support sits near the 50-day average €73.54 and resistance near €80.14 yearly high. Consumer Defensive peers trade at an average PE near 24.10, putting Danone slightly above sector average on PE.
Risks and near-term catalysts for BN.PA stock
Near-term downside risks include follow-up details on the infant formula recall and the investor probe reported by Pomerantz. See Reuters coverage and the legal notice for context source and source. Catalysts include management guidance, margin improvement in Specialized Nutrition, and any clarity on product safety and regulatory responses.
Final Thoughts
Danone (BN.PA) closed €74.12 on EURONEXT as markets shut on 19 Feb 2026 with earnings due tomorrow. The company combines steady cash flow, a €2.15 annual dividend, and moderate leverage. Meyka AI’s forecast measures an implied 15.23% upside to the €85.41 yearly projection and 7.46% to the quarterly €79.65 level, versus current price. On the other hand, regulatory fallout from the recall and the Pomerantz investigation add headline risk that could widen short-term volatility. For investors watching BN.PA stock, the earnings call will likely dictate direction. We recommend watching organic sales, adjusted margins, and free cash flow conversion for signal confirmation. Meyka AI provides this as AI-powered market analysis; forecasts are model-based projections and not guarantees.
FAQs
When does Danone report earnings and why does it matter for BN.PA stock?
Danone reports on 20 Feb 2026. The release matters because management will update organic growth, margins, and guidance, which can change short-term BN.PA stock direction and volatility.
What is Meyka AI’s view on BN.PA stock valuation?
Meyka AI notes a trailing PE near 26.01, price-to-sales 1.74, and free cash flow per share €4.44. The model suggests fair-value upside to €85.41 over one year, with valuation balanced by leverage risks.
What are the main risks for BN.PA stock after the recall?
Primary risks are regulatory follow-ups, litigation costs, and brand impact that could pressure sales in Specialized Nutrition. These factors may increase short-term volatility in BN.PA stock.
How does Danone’s dividend affect BN.PA stock appeal?
Danone pays €2.15 annually, about 2.97% yield. The dividend supports total return for income investors, but payout ratio near 0.75 means dividend sensitivity to earnings shifts.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)